Business · 05/01/2004Updated: 10/17/2026 · 1 min read
FDA Refers Morphine Sulfate for Pediatric Studies
The FDA has referred morphine sulfate to the Foundation for National Institutes of Health for pediatric studies, as mandated by the Best Pharmaceuticals for Children Act, following a referral on September 29, 2003.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →